LyondellBasell (LYB)

On 12 Nov 2026 LyondellBasell closed at $63.88, +52.4% this year; market cap $20.63bn, P/E 15.8.

About

Materials · Specialty Chemicals · NYSE · Netherlands

LyondellBasell Industries N.V. operates as a chemical company in the United States, Germany, China, Mexico, Italy, Japan, France, Poland, the Netherlands, and internationally. It operates in five segments: Olefins and Polyolefins"Americas; Olefins and Polyolefins"Europe, Asia, International; Intermediates and Derivatives; Advanced Polymer Solutions; and Technology. The company produces and markets olefins and co-products, such as ethylene, aromatics, propylene and butadiene; polyolefins; polyethylene; polypropylene homopolymers and copolymers; propylene oxide and derivatives; oxyfuels and related products; and intermediate chemicals, such as styrene monomer and acetyls. It also produces and markets compounding and solutions, including polypropylene compounds, engineered plastics, masterbatches, and engineered composites and colors. In addition, it develops and licenses chemical and polyolefin process technologies; and manufactures and sells polyolefin catalysts and serves food packaging, home furnishings, automotive components, and paints and coatings applications. LyondellBasell Industries N.V. was incorporated in 2009 and is headquartered in Rotterdam, the Netherlands.

Key figures

Market cap$20.63bn
P/E (trailing)15.8
EPS (TTM)$4.03
Beta0.32
Dividend$2.76
Dividend yield4.32%
Ex-dividend date24 Aug 2026
Latest report30 Oct 2026
Next earnings29 Jan 2027

Performance

YTD+52.4%
1Y+56.8%
3Y-6.1%
5Y-1.1%

Financials

YearRevenueNet incomeFree cash flow
2025$30.15bn$-743.00m$384.00m
2024$40.30bn$1.36bn$1.98bn
2023$41.11bn$2.11bn$3.41bn
2022$50.45bn$3.88bn$4.23bn
2021$46.17bn$5.61bn$5.74bn

Valuation

We publish no single base value for LyondellBasell. Our valuation methods put it between $58.29 and $91.78 a share. The valuation code's reason: no point fair value: the two anchors behind it compound the same growth rate and differ only in how they end — a perpetuity at the terminal rate against a multiple on the final year — so the midpoint between them measures terminal treatment rather than what the business is worth. The published range is the same reading with the false precision removed: read it as the span the method supports, and treat neither edge as a point estimate. See every method

Options

Call and put prices: our price for each next to the market's.

Open in the dashboard · Run a full Desk Run

Data as of 12 Nov 2026. Not investment advice.